Mind Medicine MindMed
MNMD14.8700.00% ( 0.000 )
Mind Medicine MindMed (MNMD)
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company’s lead product ca...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 14.870
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 15.290
- Volume Ratio
- 0.00
- Turnover Ratio
- --
Mind Medicine MindMed Analyst Rating
View MoreForecast & Rating
Dec 31, 2025Price forecast
$28.6792.78%
Forecast & RatingStrong buy
13analysts
- Strong buy76.92%
- Buy23.08%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- MorningStar · May 26 at 12:50 PM
New Study Conducted at Sheppard Pratt Finds Psilocybin-Assisted Therapy May Reduce Chronic Suicidal Ideation
- rttnews · Apr 24 at 04:50 PM
FDA Moves To Fast-Track Psychedelic Therapies For Mental Health
- rttnews · Apr 20 at 06:37 AM
Trump Order To Accelerate Treatments For Serious Mental Illness
- Wallstreetcn · Apr 18 at 08:14 AM
Trump: Accelerate access to research on psychedelic drugs
- businessinsider · Apr 14 at 11:02 PM
Women's health startup Midi Health hit a $1 billion valuation. Its founder says AI changed everything.
- prnewswire · Mar 24 at 10:05 AM
11:03 ETSonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems
